Clinical Trials

Through its clinical trials, Capricor Therapeutics is actively engaged in the development of novel therapeutics to prevent and treat serious diseases.

hope

INSPIRE

Completed

Capricor’s Phase 2 INSPIRE study enrolled patients who have a confirmed diagnosis of SARS-CoV-2.

Read More…

hope2

HOPE-2

Completed

Capricor completed the HOPE-2 clinical trial for Capricor’s lead investigational therapy, CAP-1002.

Read More…

hope

HOPE

PHASE I/II enrollment complete

The Halt cardiomyOPathy progrEssion in Duchenne (HOPE) Phase I/II trial will evaluate CAP-1002 in patients with Duchenne muscular dystrophy associated cardiomyopathy.

Read More…